Jade Biosciences Inc. Common Stock (JBIO)
Stock · NASDAQ · Health Care
$20.84as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$13.7
Industry
Biotechnology: Pharmaceutical Preparations
About JBIO
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc.…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 55
- Website
- jadebiosciences.com
Fundamentals
- 1-day range
- $23.38$25
- Market cap
- $945.24M
- P/E (trailing)
- —
- P/E (forward)
- -9.28
- EPS (trailing)
- $-1.07
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 1.13M
- Dividend pay date
- April 28, 2025
52-week range
$6.71$28
Next earnings: November 12, 2026 · EPS estimate $-0.57After Closeconfirmed
Forecasts
8 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$77
+269.5%
Median
$47
+125.5%
Low
$40
+91.9%
Jade Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- JBIOJade Biosciences Inc. Common Stock$20.84▼ 2.11%Market cap $945.24MP/E —$6.71$28
- JANXJanux Therapeutics Inc. Common Stock$18.01▼ 4.10%Market cap $934.28MP/E —$12.12$35.34
- OMEROmeros Corporation Common Stock$18.59▼ 3.43%Market cap $909.03MP/E 14.37$3.94$19.65
- OLMAOlema Pharmaceuticals Inc. Common Stock$10.28▼ 4.77%Market cap $985.28MP/E —$5.36$36.26
- AMPHAmphastar Pharmaceuticals Inc. Common Stock$22.01▲ 0.59%Market cap $891.56MP/E 10.93$16.65$31.26
- IVAInventiva S.A. American Depository Shares$4.71▼ 3.98%Market cap $1.00BP/E —$2.88$6.2
- ANNXAnnexon Inc. Common Stock$4.97▼ 5.33%Market cap $860.17MP/E —$2.03$7.18
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| JBIO Jade Biosciences Inc. Common Stock | $945.24M | — | $20.84 | ▼ 2.11% | $6.71$28 |
| JANX Janux Therapeutics Inc. Common Stock | $934.28M | — | $18.01 | ▼ 4.10% | $12.12$35.34 |
| OMER Omeros Corporation Common Stock | $909.03M | 14.37 | $18.59 | ▼ 3.43% | $3.94$19.65 |
| OLMA Olema Pharmaceuticals Inc. Common Stock | $985.28M | — | $10.28 | ▼ 4.77% | $5.36$36.26 |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | $891.56M | 10.93 | $22.01 | ▲ 0.59% | $16.65$31.26 |
| IVA Inventiva S.A. American Depository Shares | $1.00B | — | $4.71 | ▼ 3.98% | $2.88$6.2 |
| ANNX Annexon Inc. Common Stock | $860.17M | — | $4.97 | ▼ 5.33% | $2.03$7.18 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47Benzinga · 8/11/2026
- Jade Biosciences Q2 EPS $(0.76) Misses $(0.64) EstimateBenzinga · 8/10/2026
Insider Activity
Insider Actions →Acquired
221.9K
Disposed
0
- Mark Eisner · June 25, 2026 · Grant47.7K
- CAIN CHRISTOPHER W. · June 9, 2026 · Grant34.8K
- Lawrence Otto Klein · June 9, 2026 · Grant34.8K
- Lavelle Erin · June 9, 2026 · Grant34.8K
- Harwin Peter Evan · June 9, 2026 · Grant34.8K
- Eric Dobmeier · June 9, 2026 · Grant34.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 49.44M
- Total value held
- $693.69M
- Institutional holders
- 117
Top holders this quarter
- Unknown7.09M
- Unknown4.55M
- Unknown3.67M
- Unknown3.50M
- Unknown3.22M
- Unknown3.11M
- Unknown2.31M
- Unknown1.80M
- Unknown1.64M
- Unknown1.58M
See the full, filterable feed with live charts on the MarketWall dashboard.